It has been reported that SSRP1 is highly expressed in many cancers, including colorectal cancer (Wang et al., 2019; Wu et al., 2019), prostate cancer, lung cancer (Bi et al., 2019), bladder cancer (Song et al., 2021), breast cancer (Koman et al., 2012), malignant melanomas (Yu et al., 2021), hepatocellular carcinomas (Luo et al., 2021), and gliomas (Liao et al., 2017). This evidence concerns the gene SSRP1 and prostate cancer.